Brief: Scynexis To Receive $10 Million Milestone Payment From GSK
July 23 (Reuters) - SCYNEXIS Inc SCYX.O :
* SCYNEXIS TO RECEIVE $10 MILLION MILESTONE PAYMENT FROM GSK
TRIGGERED BY DELIVERY OF COMPLETED FURI, CARES AND NATURE
CLINICAL STUDY REPORTS
* SCYNEXIS : ELIGIBLE FOR ADDITIONAL $323 MILLION IN
MILESTONE
PAYMENTS
* SCYNEXIS INC - MILESTONE PAYMENT TRIGGERED BY CLINICAL
STUDY
REPORTS
* SCYNEXIS : GSK WILL ALSO PAY MID-SINGLE DIGIT TO MID-TEEN
DIGIT
TIERED ROYALTIES ON TOTALITY OF IBREXAFUNGERP SALES ACROSS ALL
INDICATIONS
* SCYNEXIS INC - CASH RUNWAY EXCEEDS TWO YEARS
Source text for Eikon: ID:nGNX3Sb1pN
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview